Ma H - Search Results

1

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

Yu R, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Jia J, Hou J, Xie Q, Sun J. Yu R, et al. Among authors: ma h. Hepatol Res. 2018 Feb;48(3):E213-E221. doi: 10.1111/hepr.12972. Epub 2017 Oct 4. Hepatol Res. 2018. PMID: 28834607

2

[Clinical characteristics of primary biliary cirrhosis: a report of 45 cases].

Zhang F, Jia J, Wang B, Qian L, Yin S, Wang Y, Cui Y, You H, Ma H, Wang H, Zhang C. Zhang F, et al. Among authors: ma h. Zhonghua Nei Ke Za Zhi. 2002 Mar;41(3):163-7. Zhonghua Nei Ke Za Zhi. 2002. PMID: 11940315 Chinese.

3

[Effect of compound 861 on tissue inhibitor of metalloprotenase 1 gene expression of HSC-T6 cells].

Yin C, Ma H, Wang A, Ma X, Jia J, Wang B. Yin C, et al. Among authors: ma h, ma x. Zhonghua Gan Zang Bing Za Zhi. 2002 Jun;10(3):197-9. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12113678 Chinese.

4

[Leptin and liver fibrosis].

Yin CH, Wang BE, Ma H, Jia JD, Shen FJ. Yin CH, et al. Among authors: ma h. Zhonghua Gan Zang Bing Za Zhi. 2003 Jan;11(1):60-1. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12546755 Review. Chinese. No abstract available.

5

[The effect of herbal compound 861 on mRNA levels of MMP-2 and its activities in experimental rats liver fibrosis].

Zhu Y, Yin C, Ma X, Ma H, Jia J, Wang B. Zhu Y, et al. Among authors: ma x, ma h. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Dec;16(4):348-50. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002. PMID: 12665902 Chinese.

6

[The relationship among the counts of platelet, thrombopoietin and spleen index in patients with liver cirrhosis].

Li Q, Sun GZ, Wang BE, Jia JD, Ma H, Wei YX, Cong YL, Shen J. Li Q, et al. Among authors: ma h. Zhonghua Gan Zang Bing Za Zhi. 2004 Apr;12(4):210-2. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15099468 Chinese.

7

[The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].

Shen FJ, Zhu YK, Jia JD, Ma H, Wang BE. Shen FJ, et al. Among authors: ma h. Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):605-8. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15504291 Chinese.

8

[Dynamic evolution of MMP-13, TIMP-1, type I and III collagen and their interaction in experimental liver fibrosis].

Zhu YK, Wang BE, Shen FJ, Wang AM, Jia JD, Ma H. Zhu YK, et al. Among authors: ma h. Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):612-5. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15504294 Chinese.

9

[A discussion of standardization for prothrombin time in patients with advanced liver diseases].

Li Q, Cong YL, Wang BE, Jia JD, Chen Y, Zhang FK, Ou XJ, Wei YX, Ma H. Li Q, et al. Among authors: ma h. Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):128-31. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15727702 Chinese.

10

[The value of coagulation factors in severity categorization of hepatitis B-related liver cirrhosis].

Li Q, Wang BE, Cong YL, Jia JD, Yin ZJ, Qian LX, Ma H. Li Q, et al. Among authors: ma h. Zhonghua Nei Ke Za Zhi. 2005 Mar;44(3):188-90. Zhonghua Nei Ke Za Zhi. 2005. PMID: 15840257 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,854 results

Search Page

Filters